GCF-2013-281-Sundan
Ontology highlight
ABSTRACT: Multiple Myeloma (MM) is cancer in the antibody-producing plasma cells. It comprises 1 percent of all hematological malignancies. MM is incurable and fatal. The proteasome inhibitor bortezomib has improved treatment significantly, but inherent and acquired resistance remains a problem. Glutathione (GSH) is an important red-ox buffer in eukaryotic cells. In this experiment we investigate how GSH affects bortezomib-induced gene expression changes
ORGANISM(S): Homo sapiens
SUBMITTER: Arnar Flatberg
PROVIDER: E-MTAB-2666 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA